TERN: Terns Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 326.61
Enterprise Value ($M) 246.68
Book Value ($M) 255.37
Book Value / Share 3.95
Price / Book 1.28
NCAV ($M) 254.28
NCAV / Share 3.93
Price / NCAV 1.28

Profitability (mra)
Return on Invested Capital (ROIC) -0.35
Return on Assets (ROA) -0.30
Return on Equity (ROE) -0.31

Liquidity (mrq)
Quick Ratio 22.39
Current Ratio 22.39

Balance Sheet (mrq) ($M)
Current Assets 267.43
Assets 268.52
Liabilities 13.15
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -102.56
Net Income -90.21

Cash Flow Statement (mra) ($M)
Cash From Operations -67.39
Cash from Investing -37.99
Cash from Financing 41.95

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
03-07 13G Point72 Asset Management, L.P. 6.30
02-14 13G/A Deep Track Capital, LP 9.87 71.35
02-14 13G/A Fairmount Funds Management LLC 9.90 25.86
02-14 13G/A Venrock Healthcare Capital Partners III, L.P. 7.30 21.29
02-13 13G/A Suvretta Capital Management, Llc 9.50 69.28
02-13 13G/A LAV Biosciences Fund V, L.P. 4.70 0.00
02-09 13G/A Fmr Llc 4.84 -41.57
01-31 13G BlackRock Inc. 5.50
01-25 13G Integrated Core Strategies (us) Llc 5.60
10-10 13G/A FIL Ltd 8.38
10-04 13G/A Flynn James E 0.00 -100.00
06-27 13G Millennium Management Llc 4.10

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-14 10-K i UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-15 10-Q Form 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-02 111,754 458,412 24.38
2024-05-01 197,595 271,163 72.87
2024-04-30 219,220 290,920 75.35
2024-04-29 132,197 154,116 85.78

(click for more detail)

Similar Companies
TARS – Tarsus Pharmaceuticals, Inc. TBIO – Telesis Bio, Inc.
TECH – Bio-Techne Corporation TLRY – Tilray Brands, Inc.
TNYA – Tenaya Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io